Literature DB >> 9510181

Elf-1 regulates basal expression from the T cell antigen receptor zeta-chain gene promoter.

B L Rellahan1, J P Jensen, T K Howcroft, D S Singer, E Bonvini, A M Weissman.   

Abstract

In mature T cells, limited synthesis of the TCR-zeta subunit is primarily responsible for regulating surface expression of TCRs. Transcription of zeta is directed by a complex promoter that includes two potential binding sites for the Ets family of transcription factors at -52 (zEBS1) and -135 (zEBS2). Mutation of these two sites results in a marked reduction of transcription from this promoter. Using electrophoretic mobility shift analysis, Elf-1 was demonstrated to be the Ets family member that binds to these sites. One site, zEBS1, matches the optimal Elf-1 consensus sequence in eight of nine bases, making it the best match of any known mammalian Elf-1 binding site. A role for Elf-1 in TCR-zeta trans-activation was confirmed by ectopic expression of Elf-1 in COS-7 cells. This resulted in an increase in TCR-zeta promoter activity that mapped to zEBS1 and zEBS2. Additional support for the involvement of Elf-1 in TCR-zeta trans-activation derives from the finding that a GAL4-Elf-1 fusion protein trans-activated TCR-zeta promoter constructs that had been modified to contain GAL4 DNA binding sites. These results demonstrate that Elf-1 plays an essential role in the trans-activation of a constitutively expressed T cell-specific gene, and that trans-activation occurs in the context of the native promoter in both lymphoid and nonlymphoid cells. Taken together with the existing literature, these data also suggest that the requirement for inducible factors in Elf-1-mediated trans-activation may decrease as the affinity and number of Elf-1 sites increase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510181

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells.

Authors:  Hak-Jong Choi; Yanbiao Geng; Hoonsik Cho; Sha Li; Pramod Kumar Giri; Kyrie Felio; Chyung-Ru Wang
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

2.  Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study.

Authors:  Edwin Leeansyah; Jingling Zhou; Geza Paukovics; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

3.  Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.

Authors:  Vaishali R Moulton; Andrew R Gillooly; Marcel A Perl; Anastasia Markopoulou; George C Tsokos
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

4.  The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo.

Authors:  Fiona H X Guan; Charles G Bailey; Cynthia Metierre; Patrick O'Young; Dadi Gao; Teh Liane Khoo; Jeff Holst; John E J Rasko
Journal:  J Hematol Oncol       Date:  2017-03-28       Impact factor: 17.388

5.  The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response.

Authors:  Leon Louis Seifert; Clara Si; Debjani Saha; Mohammad Sadic; Maren de Vries; Sarah Ballentine; Aaron Briley; Guojun Wang; Ana M Valero-Jimenez; Adil Mohamed; Uwe Schaefer; Hong M Moulton; Adolfo García-Sastre; Shashank Tripathi; Brad R Rosenberg; Meike Dittmann
Journal:  PLoS Pathog       Date:  2019-11-04       Impact factor: 6.823

6.  Regulation of the human LAT gene by the Elf-1 transcription factor.

Authors:  Timothy S Finco; Geri E Justice-Healy; Shivani J Patel; Victoria E Hamilton
Journal:  BMC Mol Biol       Date:  2006-02-07       Impact factor: 2.946

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.